Company Filing History:
Years Active: 2017
Title: Innovations by Alexander Melamud in Medical Technology
Introduction
Alexander Melamud is a notable inventor based in Nesher, Israel. He has made significant contributions to the field of medical technology, particularly in the area of vascular interventions. His innovative approach has led to the development of a unique method and device aimed at improving patient outcomes in the treatment of occluded blood vessels.
Latest Patents
Melamud holds a patent for a "Method and device for recanalization of total occlusions." This invention discloses an apparatus, system, and method for re-canalization or opening a passage through an occlusion in a blood vessel. The device utilizes hydraulic pressure to drive a vibratable member, making it suitable for both cardiovascular and peripheral vessels. The system includes a control unit that allows for the adjustment of the frequency or amplitude of oscillation of the vibratable member, tailored to the morphology or hardness of the target occlusion. Additionally, the patent outlines a method for adjusting the force of vibration, enhancing the effectiveness of the procedure.
Career Highlights
Melamud is associated with Medinol Ltd., a company known for its advancements in medical devices. His work at Medinol has positioned him as a key player in the development of innovative solutions for vascular treatments. His dedication to improving medical technology is evident in his patent and ongoing research efforts.
Collaborations
Some of Melamud's notable coworkers include Amir Pansky and Oleg Weizman. Their collaboration has likely contributed to the innovative environment at Medinol, fostering advancements in medical technology.
Conclusion
Alexander Melamud's contributions to the field of medical technology, particularly through his patented methods for recanalization, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of vascular occlusions, ultimately benefiting patients worldwide.